标题
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
作者
关键词
-
出版物
NATURE MEDICINE
Volume 27, Issue 7, Pages 1280-1289
出版商
Springer Science and Business Media LLC
发表日期
2021-05-20
DOI
10.1038/s41591-021-01386-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
- (2021) Sultan Abdul-Jawad et al. CANCER CELL
- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
- (2021) Hassen Kared et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
- (2020) Ling Ni et al. IMMUNITY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage
- (2020) Jingyuan Liu et al. Journal of Translational Medicine
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak
- (2020) Mengyuan Dai et al. Cancer Discovery
- Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
- (2020) Vikas Mehta et al. Cancer Discovery
- Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
- (2020) Christopher M Petrilli et al. BMJ-British Medical Journal
- Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience
- (2020) Anthony R. Mato et al. BLOOD
- Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment
- (2020) Jing Sun et al. CELL
- High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
- (2020) Souad Assaad et al. EUROPEAN JOURNAL OF CANCER
- Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
- (2020) Qianwen Zhao et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Determinants of COVID-19 disease severity in patients with cancer
- (2020) Elizabeth V. Robilotti et al. NATURE MEDICINE
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
- (2020) Sara De Biasi et al. Nature Communications
- Comprehensive mapping of immune perturbations associated with severe COVID-19
- (2020) Leticia Kuri-Cervantes et al. Science Immunology
- SARS-CoV-2 seroprevalence among parturient women in Philadelphia
- (2020) Dustin D. Flannery et al. Science Immunology
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
- (2020) Jeong Seok Lee et al. Science Immunology
- Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
- (2020) Bicheng Zhang et al. Frontiers in Molecular Biosciences
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- Prognosis of coronavirus disease 2019 (COVID‐19) in patients with HIV infection in New York City
- (2020) H Miyashita et al. HIV MEDICINE
- Chemotherapy and COVID-19 Outcomes in Patients With Cancer
- (2020) Justin Jee et al. JOURNAL OF CLINICAL ONCOLOGY
- COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET ONCOLOGY
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
- (2020) Yanchun Peng et al. NATURE IMMUNOLOGY
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
- (2020) Prabhu S. Arunachalam et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
- (2020) Elizabeth R. Mann et al. Science Immunology
- Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
- (2020) Abi Vijenthira et al. BLOOD
- Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set
- (2020) Ajai Chari et al. BLOOD
- Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
- (2020) Yapeng Su et al. CELL
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- The known unknowns of T cell immunity to COVID-19
- (2020) Annika C. Karlsson et al. Science Immunology
- Earth Mover’s Distance (EMD): A True Metric for Comparing Biomarker Expression Levels in Cell Populations
- (2016) Darya Y. Orlova et al. PLoS One
- Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies
- (2015) Alistair M. Cook et al. OncoImmunology
- Performance Status in Patients With Cancer
- (2015) Howard (Jack) West et al. JAMA Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now